// App-Quantinova.ai

PB2267 : COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY

Researchers

Presenter

  • Laya Hariharan

Principal Investigators

  • Max Champion-Homfray

  • Eman Hassan

Medical Centers

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Соединённое Королевство

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

  • Haematology,Russells Hall hospital, NHS foundation trust,Brimingham,Reino Unido

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Severe COVID-19 pneumonia

  • Lymphomas

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved